Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

NCT01240538 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

NIH

Sponsor class

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: wild-type reovirus
DRUG: cyclophosphamide
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)